Abstract
Challenges and opportunities within peptide ADME (absorption, distribution, metabolism and elimination) were presented and discussed at the 3rd online workshop of the Peptide ADME Discussion Group (3rd of February 2021). This article summarises the presentations and discussions from this workshop.
The following topics were covered:
Peptide drug-drug interactions
Impact of septic shock on PK and PD of the peptide selepressin
MS processing software for metabolite identification of peptides
Profiling of peptides in preclinical drug development
Strategy for immunogenicity testing of peptides
In vitro stability testing of peptides for inhalation and automated LC-MS
Acknowledgements
The organisers thank all speakers for their contributions, and to all participants for fruitful discussions. The authors acknowledge also the DMDG organising and technical team, in particular Stuart Hex and Chris Barron (AssociAction Enterprises).
Disclosure statement
The authors declare no conflict of interest, financial or otherwise.